why choose us

Course: Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants

CME Credits: 1.00

Released: 2021-05-05

Last summer, a UK man in his 70s was admitted to Addenbrooke’s Hospital in Cambridge with COVID-19 pneumonia. He hadn’t been able to shake his illness since testing positive for SARS-CoV-2 more than a month earlier. Despite interventions including multiple rounds of the antiviral remdesivir and convalescent plasma, he died in the hospital’s intensive care unit about 9 weeks after his arrival.
Throughout his hospitalization, the patient continued to test positive with a high viral load. This, along with his worsening illness, indicated that he was battling an ongoing infection with live, replicating virus for more than 100 days.


Educational Objective
To identify the key insights or developments described in this article


View Full Course